Congress Asks Center To Clarify Who Will Get Free COVID19 Vaccine, When And How

Mumbai: Congress leader Randeep Surjewala on Sunday said that the BJP-led central government should clarify when, how and how free COVID-19 vaccination will take place.

Also Read: Shiv Sena To Contest West Bengal Assembly Election

Surjewala told reporters that the government is providing vaccines to health workers, but should also clarify when these vaccines will be distributed to the rest of the country.

Also Read: Leave WhatsApp & Use Some Other App, It’s Voluntary: Delhi HC On App’s Policy

He said, “India’s Drug Controller VG Somani has said that it has purchased 16.5 million (165 lakh) doses. Of these, 5.5 million are from Covaxin Bharat Biotech and 11 million are from Covishield of Serum Institute of India. If an individual gets two doses of vaccines then it can be given to 82,500 lakh healthcare workers. Prime Minister Narendra Modi had earlier said that 3 crore vaccines would be given the first phase. The government should clarify when the remaining population of 135 crores will be vaccinated and will they get free immunization? ”

Also Read: Watch: Sanitation Worker At AIIMS Delhi Becomes First Person To Receive COVID19 Vaccine Shot In India

There were many questions about the vaccine, stating that Surjewala said, “The Serum institute is offering Covishield vaccine to government at Rs 200 per dose. They are producing the vaccine developed by AstraZeneca, which has said that they would distribute the vaccine on no profit-loss basis. One of the ministers in Belgium said that the company is providing the vaccine at $2.18 or in other words in Rs 158. So why is the Serum selling its vaccines at Rs 200 per dose?”

Also Read: SC Refuses To Pass Order On Farmers’ Tractor Rally, Says Entry Into Delhi to Be Decided By Police

“Another vaccine Covaxin is provided by Bharat Biotech for Rs 295 per dose. It has agreed to manufacture the vaccine with the help of the Indian Council of Medical Research (ICMR). The company has to provide Covaxin to only 375 people. Permitted. In the first phase, 380 in the second, and the third phase is awaiting test results. So when the vaccine has already fallen below Rs 200, why is it costing more? ”

(With ANI Inputs)

Follow us on Twitter, Instagram, and like us on Facebook for the latest updates and interesting stories.x